Thymic plasmacytoid dendritic cells (pDCs) are located predominantly in the medulla and at the corticalmedullary junction, the entry site of bone marrow derived multipotential precursor cells into the thymus, allowing for interactions between thymic pDCs and precursor cells. We demonstrate that in vitro generated pDCs stimulated with CpG or virus impaired the development of human autologous CD34 +
Introduction
In the thymus, T lymphocytes develop from bone-marrow derived multipotential precursor cells. These early thymic precursors, which enter the thymus at the cortico-medullary junction 1 , are also able to develop into NK cells, conventional dendritic cells (cDC) and plasmacytoid DC (pDCs) 2 , reviewed in 3 . Human thymic precursors express CD34 and lack surface expression of CD1a, which is initiated upon commitment to the T cell lineage 4 . Next to a small portion of TCRγδ+ T cells mostly TCRαβ+ T cells develop, which sequentially rearrange Tcell receptor (TCR) β genes followed by TCRα genes, upregulate expression of CD4 and CD8, undergo positive and negative selection, before leaving the thymus as CD3
+/hi /TCR-expressing, CD4 or CD8 single positive T cells (reviewed in 3, 5 ). The thymic microenvironment consists of a network of various cell types, including epithelial cells and dendritic cells, which play essential roles in T cell development. Thymic epithelial cells produce IL-7, the key cytokine for survival, proliferation and development of T cells in the thymus [6] [7] [8] , and are involved in positive selection of T lymphocytes. Thymic CD11c + cDCs, predominantly located in the medulla 9, 10 , are involved in negative selection (reviewed in 11 ). CD11c
-pDCs are present in the thymic medulla and at the cortical-medullary junction 9, 10, 12 , but their contribution to T cell development remains to be defined. While the function of thymic pDCs remains elusive 11 , much insight has been obtained on the role of peripheral pDCs. Human pDCs, which are characterized by high surface expression of CD123 (IL-3Rα chain) 13 and BDCA-2 and -4 14 , are present in cord-and peripheral blood as well as the T cell areas of lymph nodes. pDCs express toll-like receptors 7 (TLR7) and 9 (TLR9) 15 , which can be engaged by enveloped RNA or DNA viruses and distinct CpG oligonucleotides, which mimic bacterial DNA 16, 17 . Consequently, pDCs produce large amounts of type I interferons (IFN-α/β) 18, 19 that exert a broad array of biological functions in innate and adaptive immunity 18, [20] [21] [22] . Type I interferons modulate various aspects of the immune response such as macrophage function, CTL and NK cell activity, Th1 polarization of naïve human T cells, and differentiation and maturation of cDCs (reviewed in [22] [23] [24] ). Also, IFN-α displays potent antiviral and growth inhibitory functions and is therefore used in the treatment of viral infections, including Hepatitis C, and hematological and malignancies (rewieved in 25, 26 ). Thymic pDCs phenotypically resemble peripheral pDCs, and are able to produce IFN-α upon stimulation with virus or bacterial DNA in humans 10, 27 and in mice (reviewed in 11 ). In the mouse, high concentrations of exogenous IFN-α interfered with T cell development in vivo, resulting in a reduction of thymic cellularity by >80% and a 50% decrease in CD4 + CD8 + cells 28 . In murine fetal thymus organ cultures IFN-α/β inhibited the IL-7 driven expansion of CD4 -
CD8
-CD44 + CD25 + pro T-cells 29 .
Whether IFN-α influences human T cell development has not been addressed, but as all thymocytes express the IFN-α receptor β chain (CD118), each thymocyte subset is potentially responsive to type I IFNs 30 . In addition it was shown that IFN-α mediates terminal differentiation and subsequent apoptosis of human thymic epithelial cells which may contribute to thymic atrophy 31 . Because activated pDCs are known to produce high amounts of IFN-α, the activation of thymic pDCs could potentially adversely affect T cell development. Here we examined whether pDCs have an impact on early IL-7 induced human T cell development. We build on our recent observations that human CD34 . We observed that after stimulation with either CpG or virus pDCs impair the development of autologous progenitor cells to T cells. This is reversed by the addition of neutralizing antibodies against type I interferons, implying that T cell development is impeded by endogenous production of IFN-α/β. Subsequent experiments show that the addition of exogenous IFN-α to cell cultures counteracts IL-7 mediated T cell development.
Material and methods
Cell lines. The generation of OP9 murine bone marrow stromal cell line expressing human Notchligands Delta-Like1 (OP9-DL1) or Jagged1 (OP9-Jag1) was described before 32 -(further referred to as CD34 + CD1a -) population was sorted to a purity of >99% using a FACSAria (Becton Dickenson).
Generation of virus supernatants. PM1 T cells 33
were transfected by electroporation with 5μg of the molecular clone of CXCR4-using HIV-1 LAI . The virus containing supernatant was harvested 5 days posttransfection, filtered and stored at -80°C. The concentration of virus was determined by p24 ELISA.
Differentiation and stimulation assays. The development of pDCs and T cells was assessed by coculturing 30'000 CD34 + CD1a -progenitor cells with 25'000 OP-9-Jag1 (generating pDCs and T cells) or OP9-DL1 (generating T cells only) cells in MEMα medium with 20% FCS, 5ng/ml IL-7 (R&D Systems, Abingdon, United Kingdom) and 5 ng/ml Flt3L (gift from Dr. G. Wagemaker, Erasmus University, Rotterdam, Netherlands) without or with 10-10'000U/ml of interferon alpha-2a (IFN-α) (Roferon-A, Hoffmann La Roche, Switzerland) in 24-well plates at 37°C with 5% CO 2 . pDCs were stimulated by adding 1μg/ml CpG oligodeoxynucleotide (CpG) 2216 (ggGGGACGATCGTCgggggG; Sigma-Aldrich, St Louis, MO) or supernatant of HIV-1 LAI infected PM1 T cells (2 -150ng p24/ml) to CD34 +
CD1a
-cells cultured on OP9-Jag1 cells for 5 days. CpG 2243 (ggGGGAGCATGCTCgggggG) or supernatant of uninfected PM1 T cells served as negative control. The produced type I IFN was blocked by adding 10μl/ml of neutralizing sheep antibodies to human type I IFN (gift of Dr. I. Julkunen, National Public Health Institute, Helsinki, Finland 34, 35 ) to the culture 2-3h before addition of CpG or 1'000U IFN-α as positive control for MxA induction.
The hybrid murine/human fetal thymic organ culture (FTOC) has been decribed previously 36 . Medium was changed weekly and IFN-α was added to the culture medium at the following concentrations: day 0: 3000 U/ml; day 3: 2000 U/ml; day 5, 7 and 10: 1000 U/ml. Cells were analyzed by flow cytometry. Immunoblotting. After culturing the cells as described above, cell lysates were prepared and equal amounts of protein were analyzed by 15% (for p27 kip1 ) or 7.5% (for Rb) SDS-PAGE, transferred onto nitrocellulose membranes, and immunoblotted with the mAbs specific for p27 kip1 or Rb (BD Pharmingen). Actin levels were measured as loading controls (I19; Santa Cruz Biotechnology, Santa Cruz, CA).
GeneScan analysis of TCRB and TCRG gene rearrangement. Genomic DNA was isolated from CD34 + CD1a -postnatal thymocytes using a DNA isolation kit (Qiagen) directly after sorting or after culturing for 3, 7, 15 and 21 days on OP9-DL1 bone marrow stromal cells with 10-10'000U/ml IFN-α as described above. Multiplex PCR followed by GeneScan for analysis of TCRβ (Vβ-DJβ and Dβ-Jβ) and TCRγ (Vγ-Jγ) gene rearrangements was performed as described by the BIOMED-2 Concerted Action 38 . hi pDCs can develop from progenitor cells upon co-culture with the OP9 stromal cell line expressing the Notch-ligand Jagged1 (OP9-Jag1) 32 . Here we extend our previous findings. CD34 + CD1a -human thymic precursor cells were purified and co-cultured with the OP9-Jag1 cell line. We found that BDCA-2
Results

Notch ligand
hi pDCs first appeared after 3 days, reaching a maximum after 5-7 days, and disappeared completely after 18-20 days ( Figure 1 27, 30 . To assess the capacity of pDCs cultured on OP9-Jag1 cells to produce endogenous IFN-α, we stimulated cultures at the peak of pDC development (5-6 days) with CpG or virus (HIV-1 LAI ) and analyzed IFN-α production ( Figure 2 ). Sixteen hours after stimulation with CpG, intracellular IFN-α was detected solely in CD123 + pDCs (Figure 2a ), indicating that pDCs generated on OP9-Jag1 cells have the capability to produce IFN-α. Furthermore, we confirmed the secretion of the produced IFN-α by intracellular flow cytometric analysis of MxA, an IFN response protein (reviewed in 39 ). All human cells in the OP9-Jag1 culture expressed MxA three days after the addition of either CpG (2216), recombinant IFN-α ( Figure 2b ) or HIV-1 LAI (Figure 2c ). This is consistent with the finding, that all cells in the OP9-Jag1 culture expressed the type I interferon (CD118) receptor (data not shown) and are therefore potentially responsive to type I IFN. MxA was not detected when cells were not stimulated or following the addition of either control CpG (2243) or control supernatant from PM1 T cells (Figure 2b ). Induction of MxA expression could be blocked completely with neutralizing antibodies to type I interferons. These results indicate that pDCs derived from thymic progenitors cultured on OP9-Jag1 are competent to produce IFN-α after CpG or HIV-1 LAI stimulation.
Stimulated pDCs hamper T cell development from thymic progenitors.
Previously, we demonstrated that both T cells and pDCs develop from progenitor cells within the thymus micro-environment in vivo 2 . We also demonstrated that thymic pDC produce IFNafter stimulation with the TLR9 ligand CpG or HIV-1 virus 27 . To date, it remains unclear whether stimulated pDCs contribute to T cell development. Our observations described above allowed us to address this question. Therefore, five days after co-culture of CD34 +
CD1a
-thymic progenitor cells on OP9-Jag1 cells, cells were stimulated with either CpG or virus for 3 days. Upregulation of CD1a was used as read-out for T cell commitment and development on day 8. Addition of either CpG (2216) (Figure 3a ) or HIV-1 LAI (Figure 3b ) to the co-culture completely prevented the upregulation of CD1a expression on the developing thymocytes. In fact, CD1a expression levels did not increase any further than the level observed on day 5. As expected, expression of CD1a on cells treated with either control CpG (2243) or control PM1 supernatant did not differ from untreated control cultures. The absolute cell number or percentage of living cells did not change following 3 days of stimulation with CpG, and was only slightly reduced after HIV-1 LAI stimulation, indicating that the impaired T cell development was not due to preferential death of CD1a + cells (data not shown). Upregulation of CD1a expression on cells treated with CpG or HIV-1 LAI was observed when neutralizing antibodies to type I interferons were added at the time of stimulation, strongly suggesting that the observed block in T cell development in the presence of activated pDCs was induced by endogenous production of type I interferon. To further confirm these results, recombinant IFN-α was added at day five of coculture. Exogenously added IFN-α prevented the upregulation of CD1a expression to a similar extent as in cultures in which pDCs were stimulated with CpG or virus. This effect of recombinant IFN-α on T cell development could be counteracted by the addition of the neutralizing IFN-α/β antibodies (Figure 3a) . Thus, we show that in the OP9-Jag1 culture system stimulated pDCs inhibit T cell development, as determined by the reduced upregulation of CD1a expression on developing T cells. Our results suggest that the inhibition is solely due to endogenous production of type I interferons.
Stimulated pDCs hamper T cell development from thymic progenitors.
Previously, we demonstrated that both T cells and pDCs develop from progenitor cells within the thymus micro-environment in vivo 2 . We also demonstrated that thymic pDC produce IFN-α after stimulation with the TLR9 ligand CpG or HIV-1 virus 27 . To date, it remains unclear whether stimulated pDCs contribute to T cell development. Our observations described above allowed us to address this question. Therefore, five days after co-culture of CD34 +
CD1a
-thymic progenitor cells on OP9-Jag1 cells, cells were stimulated with either CpG or virus for 3 days. Upregulation of CD1a was used as read-out for T cell commitment and development on day 8. Addition of either CpG (2216) (Figure 3a) or HIV-1 LAI (Figure 3b) to the co-culture completely prevented the upregulation of CD1a expression on the developing thymocytes. In fact, CD1a expression levels did not increase any further than the level observed on day
+ cells (data not shown). Upregulation of CD1a expression on cells treated with CpG or HIV-1 LAI was observed when neutralizing antibodies to type I interferons were added at the time of stimulation, strongly suggesting that the observed block in T cell development in the presence of activated pDCs was induced by endogenous production of type I interferon. To further confirm these results, recombinant IFN-α was added at day five of co-culture. Exogenously added IFN-α prevented the upregulation of CD1a expression to a similar extent as in cultures in which pDCs were stimulated with CpG or virus. This effect of recombinant IFN-α on T cell development could be counteracted by the addition of the neutralizing IFN-α/β antibodies (Figure 3a) . Thus, we show that in the OP9-Jag1 culture system stimulated pDCs inhibit T cell development, as determined by the reduced upregulation of CD1a expression on developing T cells. Our results suggest that the inhibition is solely due to endogenous production of type I interferons. 
Exogenous IFN-α impairs thymic T cell development.
To examine the effect of exogenous IFN-α on human T cell development in more detail, we employed the co-culture system of OP9 cells expressing the human Notch ligand Delta-Like1 (DL1) with thymic CD34 + CD1a -progenitor cells, as previously described 32 . This OP9-DL1 culture system supports T cell development from thymic progenitor cells while pDC development is strongly inhibited. Increasing concentrations of recombinant IFN-α were added to the coculture and over time cells were analyzed cells for expression of T cell associated surface markers. We observed that addition of IFN-α dose-dependently impaired upregulation of expression of several markers involved in T cell development including CD1a, CD4, CD8, TCRαβ, TCRγδ and CD3 (Figure 4a-4e and  supplementary table) . Furthermore, downregulation of the progenitor-associated marker CD34 was delayed (not shown), strongly suggesting that IFN-α impedes the differentiation of progenitor cells. Upon withdrawal of IFN-α from the cultures differentiation of progenitor cells progressed normally, demonstrating that the inhibitory effect of IFN-α on T cell development was reversible (Figure 4f ).
These results did not specify whether IFN-α interfered with T cell development at genomic DNA levels, i.e. with TCR rearrangements. To investigate this, a qualitative multiplex PCR method was used 38 . Thymic progenitor cells from the OP9-DL1 co-culture were analyzed for the status of rearrangement of the TCRγ and TCRβ genes at various times after addition of different concentrations of IFN-α. In line with our previous findings 4 , TCRγ rearrangements were already detected in freshly isolated CD34 +
CD1a
-thymocytes (data not shown) and IFN-α did not affect progression of these already initiated TCRγ rearrangements. In two out of three donors we detected D to J rearrangements of the TCRβ locus in freshly isolated CD34 + CD1a -postnatal thymocytes (data not shown), which is consistent with earlier findings 4, 40 . In the absence of IFN-α, V-DJβ rearrangements initiated between day 7 and 15 of co-culture in this system. Consistent with the phenotypical findings described above, V-DJβ rearrangements were impaired by IFN-α in a dose dependent manner (Figure 4g ). At day 15 of the culture, levels of V-DJβ rearrangements were strongly reduced in the presence of as little as 10 U/ml IFN-α. At 21 days of culture, V-DJβ rearrangements in the 
IL-7 mediated proliferation, but not survival, of developing T cells is affected by IFN-α.
IFN-α has been used effectively in the treatment of a number of malignancies (reviewed in 25 ) because of its ability to inhibit proliferation and/or induce apoptosis in various cell types. Therefore, we examined whether exogenous IFN-α played a role in the proliferation and survival of thymic progenitor cells in the OP9-DL1 co-culture system. CD34 +
CD1a
-thymocytes co-cultured on OP9-DL1 cells in the presence of IL-7 for one week dramatically increased in cell numbers (85 ± 24 fold; n=9, Figure 5a ). Addition of 100U/ml of IFN-α or more consistently and significantly (p < 0.05 for 100U/ml, p < 0.001 for 1'000 and 10'000U/ml) decreased the expansion rate (Figure 5a ). Absolute cell numbers remained lower in the presence of IFN-α during at least 28 days. Of note, the addition of 10 U/ml IFN-α did not affect absolute cell numbers, although T cell differentiation was impaired (Figures 4a-e) . The reduced cell numbers obtained in the presence of IFN-α could be due to either increased apoptosis or reduced cell expansion. To determine whether IFN-α induced apoptosis, flow cytometric analysis was performed after AnnexinV/7-AAD staining on days 1, 2, 3, 6 and 10 of co-culture (data not shown). The percentage of apoptotic cells was not increased at any of the IFN-α concentrations tested (4 ± 2.1% Annexin-V + ; 4.1 ± 1% 7-AAD + ). Consistent with these findings, no change in expression of the anti-apoptotic protein Bcl-2 was detected after 3, 6 or 10 days of co-culture in the presence of IFN-α (Figure 5b and data not shown). Furthermore, the expression of 35 other regulators of apoptosis, simultaneously quantified by a multiplex ligation-dependent amplification method (RT-MLPA) 41 , in thymic precursors did not significantly change in cells cultured in the presence or absence of IFN-α for 1, 2, 3 or 6 days on OP9-DL1 cells, (data not shown). These findings suggest that in this culture system IFN-α did not impinge on pathways involved in either cell survival or cell death. To address whether IFN-α affected cell proliferation sorted CD34 + CD1a -thymic progenitor cells were labeled with CFSE and cocultured for 6 days on OP9-DL1 cells. Higher CFSE levels were observed when cells were cultured in the presence of increasing concentrations of IFN-α, indicating that IFN-α inhibited cell proliferation (Figure 5c ). To gain insight whether IFN-α specifically reduces the IL-7 or Notch mediated proliferation rate, thymic progenitor cells were cultured with either IL-7 (1 ng/ml) or OP9-DL1 in the presence or absence of IFN-α (Figure 5d and data not shown). We observed that the IL-7 induced proliferation rates were lower in the presence of IFN-α, both after 96 and 120 hours. Culture of thymic progenitor cells on OP9-DL1 cells in the absence of exogenous IL-7 led to massive cell death (> 90%) which prevented conclusive assessment (data not shown). Collectively, we conclude that IFN-α (ш 100 U/ml) reduces the IL-7 induced expansion, but not survival, of thymic precursors. . In addition, IL-7 induces hyperphosphorylation of the retinoblastoma (Rb) protein, eventually leading to cell cycle progression 45 . Using immunoblotting we addressed whether IFN-α interfered with the IL-7 induced p27 kip1 down-regulation or pRb hyperphophorylation in CD34 + thymocytes ( Figure 6b ). As expected, IL-7 reduced the levels of p27 kip1 protein and increased the level of pRb phosphorylation. No significant impact of IFN-α on these IL-7 mediated events was observed at 48h ( Figure 6b ) or 72h (data not shown). Consistent with these findings, no changes in the IL-7 induced increase in cell size were detected by flow cytometric analysis after addition of IFN-α (data not shown).
In conclusion, while IFN-α clearly impeded IL-7 induced T cell development and proliferation this could not be attributed to inhibition of either IL-7R proximal events, including the phosphorylation of STAT5, PI3K or Erk1/2, or IL-7R distal events, such as downregulation of p27 kip1 or hyperphosphorylation of pRb. 47 . We show here that thymic progenitors cultured on OP9-DL1 undergo TCR rearrangements leading to complete, diverse TCR rearrangements of the β and γ loci. Continuous Notch signaling of at least one to two weeks was required to induce a polyclonal TCRβ repertoire, which is consistent with findings in the mouse 48 . In contrast to OP9-DL1 cells, the OP9-Jag1 culture system supports both T cell and pDCs development from the same progenitor cells ( 32 and Figure 1 ). This allowed us to directly assess the impact of stimulated pDCs on early T cell commitment and differentiation. In the thymic environment, pDCs are located at the corticomedullary junction and in the medulla 12 . It has been reported that in mice thymic precursors enter the thymus at the cortico-medullary junction 1 , which allows for interactions of progenitor cells with pDCs. Here we show that stimulation of pDCs by either CpG or virus arrested early T cell development of thymic progenitor cells co-cultured with OP9-Jag1 cells.
The effect was mainly due to endogenous production of type I IFNs since T cell development could be rescued completely by the addition of blocking antibodies against type I IFNs. Moreover, addition of exogenous IFN-α to developing thymic precursors on OP9-DL1 cells or in mouse FTOC also impaired T cell development (Figure 4 and supplementary  figure) . These findings further supported our notion that stimulated pDC hamper T cell development by endogenous production of IFN-α. Since IL-7 is critical for survival, proliferation and development of T cells in the thymus [6] [7] [8] , we anticipated that IFN-α counteracted IL-7 induced signal transduction. In mice, a negative correlation between IL-7 and IFN-α signaling was suggested previously as IFN-α inhibited IL-7 driven proliferation of CD3-CD4-CD8-thymocytes in vitro 29 . In addition, treatment of newborn mice with high doses of IFN-α resulted in a reduction of thymic cellularity by >80% and a 50% decrease in CD4+CD8+ cells 28 . Importantly, the window of sensitivity of the developing thymocytes to IFN-α corresponded closely to the stages during which IL-7 signaling is essential. While here we describe the effects of IFN-a on early human T cell development, we also observed that IFN-α interfered with IL-7 induced maturation at later stages of thymocyte development, at the transition of CD3 +
+ to CD3 +/hi CD1a − (data not shown). This indicates that IFN-α also in humans affects those stages of T cell development in the thymus that are dependent on the presence of IL-7 49 . Unraveling the molecular mechanisms of IFN-α mediated effects on early T cell development is complicated. Phosphorylation of known downstream effector molecules of the IL-7R signal transduction pathway, including Akt/PKB, STAT5, and Erk1/2 7, 42 , was not affected by addition of IFN-α, suggesting that the negative effects of IFN-α were not due to IL-7 receptor proximal signaling events. Further downstream signaling events induced by IL-7 include Bcl-2 upregulation, which is critical for survival of immature thymocytes 6 , and downregulation of the cyclin-dependent kinase inhibitor p27 kip1 followed by phosphorylation of the retinoblastoma protein Rb and E2F driven transcription, which mediate cell cycle progression 45 . In the primary human thymocytes analyzed here we observed that Bcl-2 was expressed in IL-7 treated cells. In addition, we observed that IL-7 destabilized p27 kip1 protein and phosphorylated pRb. These events, however, were either not or only weakly affected by IFN-α. Therefore, we consider it unlikely that IFN-α interferes with these IL-7 receptor induced distal events. Almost all leukocytes can produce IFN-α, but pDCs secrete the highest amounts of IFN-α. In vivo IFN-α is produced locally after stimulation by bacterial or viral infections and elevated levels are found in peripheral blood during chronic immune activation, as observed in chronic viral infections and autoimmune diseases such as systemic lupus erythematosus. As primary producers of IFN-α, pDCs likely play an important role in the immune response against viruses. In this respect, we have shown recently that if stimulated to produce IFN-α, pDCs can slow HIV-1 replication 27 . The IFN-α response generated by HIV-1 alone, however, was insufficient to completely control virus replication and therefore failed to prevent HIV-1 pathogenesis in the thymus. Our data indicate that despite its favorable short term anti-viral effects, continual virus induced production of IFN-α by pDCs in the thymus can be harmful. HIV-1 induced IFN-α may up-regulate MHC class I on thymic epithelial cells 30 and result in preferential selection of dysfunctional CD4 -CD8 + thymocytes 50 . We show here that pDCderived endogenous IFN-α directly impedes early T-cell lymphopoiesis. The presence of high levels of IFN-α may prevent T cell regeneration in HIV-1 infection and contribute to the depletion of developing T cells by HIV-1 51 . IFN-α is widely used for treatment of hematological and solid malignancies and viral infections, in particular chronic Hepatitis C 25, 26 . Exogenous IFN-α as a therapy may enhance the impact of locally produced IFN-α by pDCs in the thymus. In fact, leukopenia is a common side effect of IFN-α treatment (reviewed in 52 ). The effects of exogenous IFN-α on early T cell development that we describe here may portray the side effects of IFN-α treatments and therefore needs to be considered when applying IFN-α therapy to patients, especially in children, where peripheral T cells are predominately maintained through the production of naïve T cells by the thymus 53 .
